Benefit of nectin-4 targeting with enfortumab vedotin confirmed
Crossref DOI link: https://doi.org/10.1038/s41585-021-00449-1
Published Online: 2021-03-10
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2021-03-10
Version of Record valid from 2021-03-10
Article History
First Online: 10 March 2021